Biotin-H10
Biotin-H10 is a specific anterior gradient homolog 2 (AGR2) inhibitor with a KD of 6.4 nM. Biotin-H10 inhibits cancer cells viability[1].
Product Specifications
UNSPSC
12352209
Target
MDM-2/p53; Others
Type
Peptides
Related Pathways
Apoptosis; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/biotin-h10.html
Purity
98.94
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NCC(NCC(N[C@@H](CO)C(NCC(N[C@@H](CCSC)C(N[C@@H](CCCCN)C(N[C@@H](CCSC)C(N[C@@H](CCC(N)=O)C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CC(C)C)C(N[C@@H](C(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CNC(CCCC[C@H]2[C@]3([H])[C@@](CS2)([H])NC(N3)=O)=O
Molecular Formula
C79H132N22O21S3
Molecular Weight
1822.22
References & Citations
[1]Garri C, et al. Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2) . Oncotarget. 2018 Jun 8;9 (44) :27363-27379.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
